A mixed bag for the industry in Trump executive order on medicine pricing

The US biopharmaceutical industry will welcome the Trump administration's move to scrap the so-called 'pill penalty' introduced as part of the Biden administration's Inflation Reduction Act but will be less supportive of other proposed measures. …